About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,541 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,541 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 501-520 of 22,541 trials

CompletedOpen Label Extension Study of BifeprunoxA one year extension study using flexible doses, 20 or 30 mg daily, of open-label bifeprunox.NCT00366171·Little Rock, Arkansas and 82 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

CompletedOptimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract DysfunctionThe purpose of this study is to evaluate and standardize the way providers perform OnabotulinumtoxinA (BTX-A) injections into the bladder for the diagnosis of neurogenic lower…NCT06059066·Houston, Texas

CompletedA Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage TherapyThe purpose of this study is to see if it is safe and effective to give HE2000, an experimental anti-HIV drug, to HIV-infected patients on salvage therapy (emergency treatment…NCT00002422·Palm Springs, California and 5 others

RecruitingEvaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans SyndromeThis study investigates a type of cell, called abnormal clonogenic epithelial cells, in patients with bronchiolitis obliterans syndrome who have had an donor stem cell transplant…NCT04604522·Houston, Texas

Active not recruitingLenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid CancerThis phase II trial studies how well lenvatinib and pembrolizumab work in treating patients with anaplastic thyroid cancer that is stage IVB and has spread to nearby tissue or…NCT04171622·Houston, Texas

RecruitingA Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's LymphomaThis study is a Phase II single-center clinical trial designed to assess the efficacy, safety, and tolerability of pembrolizumab in combination with the 7-day regimen of…NCT05355051·Houston, Texas

RecruitingA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dose (MED) and/or…NCT06022029·Los Angeles, California and 15 others

Active not recruitingPhysician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by SurgeryThis randomized phase III trial studies how well pembrolizumab works compared with the current standard of care, physician/patient choice of either high-dose recombinant…NCT02506153·Birmingham, Alabama and 575 others

CompletedSafety and Efficacy of K-134 for the Treatment of Intermittent ClaudicationThe purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.NCT00783081·Tucson, Arizona and 41 others

Active not recruitingA Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantPrimary Objective: -To demonstrate the benefit of isatuximab in combination with bortezomib, lenalidomide, and dexamethasone in the prolongation of progression free survival…NCT03319667·Fort Myers, Florida and 103 others

Active not recruitingPhase 2 Study of Alisertib Therapy for Rhabdoid TumorsThis study incorporates alisertib, the small-molecule inhibitor of Aurora A activity, in the treatment of patients younger than 22 years of age.NCT02114229·Palo Alto, California and 8 others

TerminatedUse of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant PatientsThis protocol is designed to obtain information on the drug levels, metabolism, and safety of daclizumab (Zenapax(R)) in children and adolescents undergoing cardiac…NCT00284531·Houston, Texas

CompletedStudy of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)A multi-center evaluation of aldafermin in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis.NCT04210245·Glendale, Arizona and 48 others

TerminatedPrevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain SyndromesPrimary Objective: 1\. To determine the prevalence of secondary hypogonadism in male patients on chronic opioid therapy for cancer-related pain syndromes.NCT00529230·Houston, Texas

CompletedPalliative Care and Symptom Management for the Pediatric Oncology PatientThe goal of this study is to learn about the communication, decision-making, symptom management, emotional adjustment, and spiritual needs of parents and pediatric patients…NCT00675467·Houston, Texas

Active not recruitingCORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.NCT05681351·Los Angeles, California and 261 others

CompletedEverolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232TThis trial is evaluating the use of oral Everolimus to determine if there is a reduction in the size of the disfiguring cutaneous lesions in patients with Neurofibromatosis 1 over…NCT02332902·Houston, Texas

CompletedDetermine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDThe purpose of this study is to assess the bronchodilator effect and safety of multiple daily doses of arformoterol administered for 12 weeks as maintenance treatment in patients…NCT00064402·Jasper, Alabama and 64 others

CompletedHLA-B*5701 And Hypersensitivity To AbacavirThis retrospective case-control study is being conducted to estimate the sensitivity of the pharmacogenetic marker, HLA-B\*5701 for hypersensitivity to abacavir (ABC HSR).NCT00373945·Birmingham, Alabama and 54 others

CompletedA Comparison of Cognitive Function After Carotid Endarterectomy and StentingThis study compares cognitive function after carotid endarterectomy and stenting.NCT02220595·Houston, Texas

PreviousPage 26 of 1128Next

in Houston

Heart Diseasein Houston